This is the authors' abstract. We don't add key points for this paper.
In February 2018, the Melanoma Research Foundation and the Moffitt Cancer Center hosted the Second Summit on Melanoma Central Nervous System Metastases in Tampa, Florida. The meeting included investigators from multiple academic centers and disciplines. A consensus summary of the progress and challenges in melanoma parenchymal brain metastases was published (Eroglu et al., Pigment Cell & Melanoma Research, 2019, 32, 458). Here, we will describe the current state of basic, translational, clinical research, and therapeutic management, for melanoma patients with leptomeningeal disease. We also outline key challenges and barriers to be overcome to make progress in this deadly disease.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Glitza et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: